John Garlich, MD
Orthopaedic Surgery · Los Angeles, CANPI 1700236841
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (42.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Arthrex at 51.8% of the total. Reporting peaked in 2020 at $10,279 and has fallen 87.7% since, to $1,260 in 2025.
Across 134 payments — averaging $175.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$12K
- Globus Medical$4K
- Stryker$3K
- Medical Device Business Services, Inc.$2K
- Johnson & Johnson$841
- Bone Support Inc.$147
- plus $1K from 12 others
What the payments were for
- Grants$10,00043%
- Travel & lodging$4,88421%
- Food & beverage$7,40432%
- Education$1,2005%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 14 | $12,155 |
| Globus Medical | 35 | $4,085 |
| Stryker | 38 | $3,321 |
| Medical Device Business Services, Inc. | 12 | $1,936 |
| Johnson & Johnson | 22 | $841 |
| Bone Support Inc. | 1 | $147 |
| Micromed Inc | 1 | $142 |
| Medinc Of Texas | 1 | $142 |
| US Implant Solutions, LLC | 1 | $142 |
| Nuvasive Specialized Orthopedics, Inc. | 1 | $141 |
| Smith+Nephew | 1 | $123 |
| Integra Lifesciences Corporation | 1 | $105 |
| Next Science LLC | 1 | $83 |
| Extremity Medical | 1 | $39 |
| Biocomposites Inc | 1 | $23 |
| Orthofix Medical, Inc. | 1 | $21 |
| Dynasplint Systems Inc. | 1 | $21 |
| Zimmer Biomet | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Clavical Fixation (16-186)$2,106
- ATTUNE$1,842
- ACTIS$1,724
- T2$668
- Anthem$584
- GAMMA$459
- VARIAX$419
- PANGEA$326
- A/R Femoral Nail$311
- PROFYLE$174
- Autobahn$174
- PELVIS II$173
- PRIME SERIES$161
- PRO$156
- T2 ALPHA$156
- CERAMENTBONE VOID FILLER$147
- CERAMENT G$147
- PRECICE Intramedullary Limb Lengthening System$141
- AXSOS$140
- Tibial Nail$139
How this compares
$23,488 in reported general payments places this provider in the 80th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Los Angeles
- Kelly VinceLos Angeles$9.6M
- Jay LiebermanLos Angeles$4.8M
- Thomas SchmalzriedLos Angeles$4M
- David SkaggsLos Angeles$2.6M
- David ThordarsonLos Angeles$2.5M
- Edward McPhersonLos Angeles$1.2M
- Daniel AllisonLos Angeles$1.1M
- Justin SalimanLos Angeles$912K
- Charles MoonLos Angeles$760K
- Andrew SpitzerLos Angeles$738K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.